WO2019008210A3 - Microparticules comprenant une composition permettant une résection endoscopique - Google Patents

Microparticules comprenant une composition permettant une résection endoscopique Download PDF

Info

Publication number
WO2019008210A3
WO2019008210A3 PCT/ES2018/070478 ES2018070478W WO2019008210A3 WO 2019008210 A3 WO2019008210 A3 WO 2019008210A3 ES 2018070478 W ES2018070478 W ES 2018070478W WO 2019008210 A3 WO2019008210 A3 WO 2019008210A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
microparticles
resection
endoscopic resection
hyaluronic acid
Prior art date
Application number
PCT/ES2018/070478
Other languages
English (en)
Spanish (es)
Other versions
WO2019008210A2 (fr
Inventor
José Antonio MORALES MOLINA
Beatriz CLARES NAVEROS
Francisco Javier GALLEGO ROJO
María José MARTÍN VILLENA
Cristina MOLES ARANDA
Original Assignee
Universidad De Granada
Servicio Andaluz De Salud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad De Granada, Servicio Andaluz De Salud filed Critical Universidad De Granada
Publication of WO2019008210A2 publication Critical patent/WO2019008210A2/fr
Publication of WO2019008210A3 publication Critical patent/WO2019008210A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Abstract

La présente invention concerne une préparation combinée qui comprend au moins une microparticule et une composition, de préférence une solution pharmaceutique aqueuse, qui comprend un polymère dérivé de cellulose soluble dans l'eau et de l'acide hyaluronique, de préférence de la carboxyméthylcellulose et de l'acide hyaluronique. L'invention concerne également l'utilisation de ladite préparation combinée pour la préparation d'un médicament destiné au traitement de lésions des muqueuses par résection endoscopique, par exemple la résection de polypes et/ou de tumeurs de la muqueuse gastro-intestinale.
PCT/ES2018/070478 2017-07-04 2018-07-04 Microparticules comprenant une composition permettant une résection endoscopique WO2019008210A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP201730889 2017-07-04
ES201730889 2017-07-04

Publications (2)

Publication Number Publication Date
WO2019008210A2 WO2019008210A2 (fr) 2019-01-10
WO2019008210A3 true WO2019008210A3 (fr) 2019-03-07

Family

ID=64949756

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2018/070478 WO2019008210A2 (fr) 2017-07-04 2018-07-04 Microparticules comprenant une composition permettant une résection endoscopique

Country Status (1)

Country Link
WO (1) WO2019008210A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150099928A1 (en) * 2013-10-07 2015-04-09 Boston Scientific Scimed, Inc. Injectable compositions
WO2016074794A1 (fr) * 2014-11-13 2016-05-19 Merz Pharma Gmbh & Co. Kgaa Charge dermique à base d'acide hyaluronique réticulé et de lubrifiant de carboxyméthylcellulose

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150099928A1 (en) * 2013-10-07 2015-04-09 Boston Scientific Scimed, Inc. Injectable compositions
WO2016074794A1 (fr) * 2014-11-13 2016-05-19 Merz Pharma Gmbh & Co. Kgaa Charge dermique à base d'acide hyaluronique réticulé et de lubrifiant de carboxyméthylcellulose

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HIKICHI T. ET AL.: "Sal766 Novel Injection Technique: Endoscopic Submucosal Dissection by Submucosal Injection of Sodium Carboxymethylcellulose for Early Gastric Cancer", GASTROINTESTINAL ENDOSCOPY, vol. 75, no. 4S, 2012, pages AB269, XP028920348 *
URAOKA T. ET AL.: "Submucosal injection solution for gastrointestinal tract endoscopic mucosal resection and endoscopic submucosal dissection", DRUG DESIGN, DEVELOPMENT AND THERAPY, vol. 2, 2008, pages 131 - 138, XP009504388 *

Also Published As

Publication number Publication date
WO2019008210A2 (fr) 2019-01-10

Similar Documents

Publication Publication Date Title
WO2018033254A3 (fr) Arn pour la cancérothérapie
PH12015502539B1 (en) Cenicriviroc compositions and methods of making and using the same
MX2023006541A (es) Formulaciones de dosis fija.
WO2015120110A3 (fr) Nouvelles formulations pharmaceutiques
NZ709260A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
MY165624A (en) N-acylsulfonamide apoptosis promoters
EP3626253A3 (fr) Formulations stables de linaclotide
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
UA109534C2 (uk) Співкристали трамадолу і коксибів
SG176687A1 (en) Solid compositions comprising 5-aminolevulinic acid
JP2018535236A5 (fr)
NZ721500A (en) Use of halogen compounds for the treatment and prevention of heart attack and ischemic injury
EA201291089A1 (ru) Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
NZ605444A (en) Salt and solvates of a tetrahydroisoquinoline derivative
MX2018002732A (es) Composicion y dispositivo medico que comprenden acido acetilsalicilico para el tratamiento de infecciones cutaneas por virus de papiloma humano.
WO2018056937A3 (fr) Barrière d'adhérence nano-fibreuse
HRP20171330T1 (hr) Postupak za proizvodnju i korištenje kopolimera natrijeve karboksimetil celuloze i gosipola
BR112017009510A2 (pt) composições compreendendo ciclosporina
WO2008148573A3 (fr) Médicaments contenant une combinaison de principes actifs pour traiter les symptomes allergiques
HK1173380A1 (en) Co-crystals of tramadol and coxibs
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
MX2011008261A (es) FORMULACIONES FARMACEUTICAS DE PEPTIDOS INHIBIDORES DE TGF-ß1.
WO2016140933A3 (fr) Compositions d'ibuprofène solubles à libération immédiate
WO2016100949A3 (fr) Procédé et compositions permettant de dissoudre ou de solubiliser des agents thérapeutiques
UA113151C2 (xx) Застосування композиції, що містить антимікробний поліпептид, у виробництві лікарського засобу

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18828222

Country of ref document: EP

Kind code of ref document: A2